The Boardroom Carousel

In professional sports, there is a familiar pattern.

The same coaches move from team to team. They have won before, built reputations, and proven they can lead under pressure.

Mike McCarthy is a good example. He won a Super Bowl in Green Bay, had a very different run in Dallas, and now enters another chapter in Pittsburgh. Only time will tell how it plays out, but the broader point is clear: past success matters, but so do fit, timing, and context.

Life sciences boards can fall into a similar pattern.

In 2026, the expectations placed on boards are changing quickly. Capital is more selective. Clinical development is more complex. New technologies are reshaping how companies think about development and commercialization. Commercial planning is happening earlier. Decisions are moving faster, and the margin for error is smaller.

In that environment, the question is not whether experience matters. It does.

The question is whether boards are relying too heavily on familiar profiles, even though the company’s needs may have changed.

 

When Familiarity Becomes the Filter

Across life sciences, certain board candidates come up often for good reason.

They have built strong reputations, served companies well, and brought real value to the boardroom.

But when those profiles become the starting point for every search, the candidate pool can narrow before the board has fully defined what it actually needs.

That is where companies can miss strong candidates.

Experienced directors should absolutely be part of the conversation. But the process also needs to be broad enough to identify the best fit for the company’s current stage, priorities, and challenges.

 

What Makes Someone Qualified for a Life Sciences Board Today?

Prior board experience, established networks, and a track record of service all carry weight. But they are not the only ways to measure board value.

Many experienced board members are no longer operating inside companies day to day. Some are retired. Some are several years removed from operating roles. Their experience is valuable, but it may be shaped by a different market, a different capital environment, and a different pace of decision-making.

At the same time, many executives who have not yet served on a board are making decisions every day in the current environment. They are dealing with capital constraints, clinical development decisions, regulatory complexity, commercialization planning, and strategic pivots in real time.

A first-time board member does not mean an inexperienced board member. In many cases, it means someone who has not yet had the opportunity to bring highly relevant operating experience into the boardroom.

It is important to remember that every board member was a first-time board member at some point.

 

When Board Members Are Stretched Too Thin

There is also a capacity issue that boards need to consider.

Many experienced board members serve on multiple boards at the same time. On paper, that can signal credibility and demand.

In practice, it can create limitations.

Time and attention are finite. As board seats accumulate, it becomes harder to stay meaningfully engaged with each company. That can show up in subtle ways. Less time between meetings. Less familiarity with program details. Less connection to how quickly the business is evolving.

This is not about questioning credentials. It is about being realistic about time, attention, and involvement.

In a market where decisions are moving quickly, engagement matters.

 

Why First-Time Board Members Deserve a Closer Look

First-time board members bring a different dynamic.

They are often highly prepared, deeply engaged, and motivated to contribute. They bring current operating experience and, in many cases, networks that are relevant to today’s market.

Clinical development. Capital raising. Commercial strategy. Market access. Regulatory planning. Scaling teams. Managing through volatility.

These are not theoretical issues for current operators. They are living them.

That does not replace experienced board members. It complements them.

The strongest boards are rarely made up of a single profile. They tend to have the right mix of experience, relevance, and engagement for where the company is today.

 

What Boards Should Be Asking in 2026

Experience matters, but it should not be the only filter.

Instead of defaulting to the same familiar names and profiles, boards may benefit from asking:

• Where do we need current operating perspective?
• Where would a fresh voice add value?
• Are we choosing familiarity, or fit?
• Are we defining “qualified” based on what worked before, or what the company needs now?

First-time board members are not the answer for every company or every board seat.

But they should be part of the conversation more often than they are.

Because in today’s boardroom, the better question is whether they bring the perspective, commitment, and relevance the company needs right now.